You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
仁和藥業與西部證券戰略合作,產融聯合助力健康事業蓬勃發展
格隆匯 06-06 11:33

5月21日,仁和藥業正式宣佈與國內領先的綜合金融服務商西部證券達成全面戰略合作協議。此舉標誌着兩大行業巨頭將在資本與產業領域展開深度協同,共同探索高質量發展的創新路徑,為雙方戰略升級注入強勁動能。

深度協同,構建全方位戰略伙伴關係

根據協議,仁和藥業與西部證券將充分發揮各自在產業資源、資本運作、金融服務及市場拓展等方面的核心優勢,建立長期、穩定、互惠的戰略合作關係。合作範圍預計涵蓋資本市場融資服務、產業投資與併購支持、資產管理優化、金融創新研究等多個關鍵領域。西部證券將憑藉其專業的金融服務能力,為仁和藥業提供定製化的綜合金融解決方案,助力企業戰略目標的實現與突破。

強強聯合,樹立產融結合新標杆

此次合作是仁和藥業深化資本佈局、優化產業結構的關鍵一步,也是西部證券深耕產業金融服務、拓展優質客户生態的重要里程碑。雙方的合作高度契合國家推動金融服務實體經濟、促進產業與資本深度融合的政策導向。

仁和藥業作為國內領先的集藥品、大健康產品研發、生產、銷售於一體的現代醫藥企業。此次與西部證券的合作,不僅能助力產業升級,加速核心產業的資本運作效率,為重大項目落地、技術創新研發及產業鏈整合提供堅實的資本後盾;更能通過雙方資源深度嫁接與互補引領行業創新,共同探索新興產業投資機會,挖掘新的增長點,提升整體競爭力。

展望未來,共繪高質量健康發展

仁和藥業與西部證券均對合作前景充滿信心。雙方將以此次簽約為起點,秉持"開放共享、互利共贏"的原則,不斷深化互信,務實推進合作項目落地生根、開花結果。通過建立高效溝通機制,持續探索合作深度與廣度,共同致力於打造金融資本與實體經濟深度融合的成功典範。為股東、客户創造更大的長遠價值,也為健康行業的蓬勃發展注入源源動力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account